Suchergebnisse - "Hanzawa, Hiroyuki"

PubPharm (52)

1

Recognition Mechanism of a Novel Gabapentinoid Drug, Mirogabalin, for Recombinant Human α2δ1, a Voltage-Gated Calcium Channel Subunit

enthalten in: Journal of molecular biology | 2023

von Kozai, D. | Numoto, N. | Nishikawa, K. | +9

2

Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Hamasuna, R. | Hanzawa, H. | Moritomo, A. | +6

3

Conformational Plasticity of Cyclic Ras-Inhibitor Peptides Defines Cell Permeabilization Activity

enthalten in: Angewandte Chemie (International ed. in English) | 2021

von Takeuchi, K. | Misaki, I. | Tokunaga, Y. | +5

4

Conformational Plasticity of Cyclic Ras‐Inhibitor Peptides Defines Cell Permeabilization Activity

enthalten in: Angewandte Chemie | 2021

von Takeuchi, K. | Misaki, I. | Tokunaga, Y. | +5

5

Conformational Plasticity of Cyclic Ras‐Inhibitor Peptides Defines Cell Permeabilization Activity

enthalten in: Angewandte Chemie International Edition | 2021

von Takeuchi, K. | Misaki, I. | Tokunaga, Y. | +5

6

Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery

enthalten in: Journal of biomolecular NMR | 2020

von Hanzawa, H. | Shimada, T. | Takahashi, M. | +1

7

Targeting the cryptic sites : NMR-based strategy to improve protein druggability by controlling the conformational equilibrium

enthalten in: Science advances | 2020

von Mizukoshi, Y. | Takeuchi, K. | Tokunaga, Y. | +7

8

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Papadopoulos, K. | Borazanci, E. | Shaw, A. | +21

9

Crystal structure of the mineralocorticoid receptor ligand-binding domain in complex with a potent and selective nonsteroidal blocker, esaxerenone (CS-3150)

enthalten in: FEBS letters | 2020

von Takahashi, M. | Ubukata, O. | Homma, T. | +7

10

Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery

enthalten in: Journal of biomolecular NMR | 2020

von Hanzawa, H. | Shimada, T. | Takahashi, M. | +1

1
2
3
4
5
6
Nächster »
[6]